217 related articles for article (PubMed ID: 4275234)
1. The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+,K+-adenosine triphosphatase interaction.
Wallick ET; Dowd F; Allen JC; Schwartz A
J Pharmacol Exp Ther; 1974 May; 189(2):434-44. PubMed ID: 4275234
[No Abstract] [Full Text] [Related]
2. The nature of the transport adenosine triphosphatase-digitalis complex. VIII. The relationship between in vivo-formed (3-H-ouabain-Na+, K+-adenosine triphosphatase) complex and ouabain-induced positive inotropism.
Allen JC; Entman ML; Schwartz A
J Pharmacol Exp Ther; 1975 Jan; 192(1):105-12. PubMed ID: 123584
[TBL] [Abstract][Full Text] [Related]
3. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
Tobin T; Akera T; Ku D; Lu MC
Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
[No Abstract] [Full Text] [Related]
4. Dissociation of the positive inotropic action of digitalis from inhibition of sodium- and potassium-activated adenosine triphosphate.
Okita GT; Richardson F; Roth-Schechter BF
J Pharmacol Exp Ther; 1973 Apr; 185(1):1-11. PubMed ID: 4266379
[No Abstract] [Full Text] [Related]
5. Effects of inhibitors of (Na plus, plus, K plus)-dependent adenosine triphosphatase on the uptake of norepinephrne by synaptosomes.
White TD; Keen P
Mol Pharmacol; 1971 Jan; 7(1):40-5. PubMed ID: 4251728
[No Abstract] [Full Text] [Related]
6. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.
Albers RW; Koval GJ; Siegel
Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893
[No Abstract] [Full Text] [Related]
7. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase.
Taniguchi K; Iida S
Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958
[No Abstract] [Full Text] [Related]
8. Membrane adenosine triphosphatase. The effect of potassium on the formation and dissociation of the ouabain-enzyme complex.
Akera T; Brody TM
J Pharmacol Exp Ther; 1971 Mar; 176(3):545-57. PubMed ID: 4255765
[No Abstract] [Full Text] [Related]
9. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.
Schwartz A; Allen JC; Harigaya S
J Pharmacol Exp Ther; 1969 Jul; 168(1):31-41. PubMed ID: 4240030
[No Abstract] [Full Text] [Related]
10. Further studies on the correlation between the inotropic action of ouabain and its interaction with the Na+,K+-adenosine triphosphatase: isolated perfused rabbit and cat hearts.
Schwartz A; Allen JC; Van Winkle WB; Munson R
J Pharmacol Exp Ther; 1974 Oct; 191(1):119-27. PubMed ID: 4278708
[No Abstract] [Full Text] [Related]
11. Dissociation of electrophysiological and inotropic actions of strophanthidin-3-bromoacetate: possible role of adenosine triphosphatase in the maintenance of the myocardial transmembrane Na + and K + gradients.
ten Eick RE; Bassett AL; Okita GT
J Pharmacol Exp Ther; 1973 Apr; 185(1):12-23. PubMed ID: 4266378
[No Abstract] [Full Text] [Related]
12. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
Wilson WE; Sivitz WI; Hanna LT
Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
[No Abstract] [Full Text] [Related]
13. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate.
Tobin T; Akera T; Hogg RE; Brody TM
Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124
[No Abstract] [Full Text] [Related]
14. Nucleotide specificity of the Na + -stimulated phosphorylation and ( 3 H)ouabain-binding reactions of (Na + + K + )-dependent adenosine triphosphatase.
Tobin T; Baskin SI; Akera T; Brody TM
Mol Pharmacol; 1972 Mar; 8(2):256-63. PubMed ID: 4260223
[No Abstract] [Full Text] [Related]
15. The binding of tritiated ouabain to sodium- and potassium-activated adenosine triphosphatase and cardiac relaxing system of perfused dog heart.
Allen JC; Besch HR; Glick G; Schwartz A
Mol Pharmacol; 1970 Jul; 6(4):441-3. PubMed ID: 4246826
[No Abstract] [Full Text] [Related]
16. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
Yoda A; Yoda S
Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
[No Abstract] [Full Text] [Related]
17. Nature of the transport adenosine triphosphatase digitalis complex. IV. Evidence that sodium-potassium competition modulates the rate of ouabain interaction iwth (Na + +K + ) adenosine triphosphatase during enzyme catalysis.
Lindenmayer GE; Schwartz A
J Biol Chem; 1973 Feb; 248(4):1291-300. PubMed ID: 4265644
[No Abstract] [Full Text] [Related]
18. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
Yoda A
Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
[No Abstract] [Full Text] [Related]
19. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
Solomonson LP; Halabrin PR
Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
[TBL] [Abstract][Full Text] [Related]
20. Physiologic and pharmacologic roles for the cardiac Na+, K+Atpase transport system.
Allen JC; Schwartz A
Recent Adv Stud Cardiac Struct Metab; 1972; 1():30-3. PubMed ID: 4283442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
